Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity

References

• Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN. 1991. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol. 9:491–498.
   PubMed Web of Science ®Google Scholar
• Achim M, Tomuta I, Muntean D, Porfire A, Tefas LR, Patras L, Licarete E, Alupei MC, Vlase L, Banciu M. 2017. Optimization and in vitro evaluation of 5-fluorouracil – loaded long – circulating liposomes. Farmacia. 65:82–91.
   Web of Science ®Google Scholar
• Barichello JM, Morishita M, Takayama K, Nagai T. 1999. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm. 25:471–476.
   PubMed Web of Science ®Google Scholar
• Bian Y, Gao D, Liu Y, Li N, Zhang X, Zheng RY, Wang Q, Luo L, Dai K. 2015. Preparation and study on anti-tumor effect of chitosan-coated oleanolic acid liposomes. RSC. 5:18725–18732.
   Web of Science ®Google Scholar
• Bilati U, Allémann E, Doelker E. 2005. Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method-processing and formulation issues for enhanced entrapment efficiency. J Microencapsul. 22:205–214.
   PubMed Web of Science ®Google Scholar
• Briuglia ML, Rotella C, McFarlane A, Lamprou DA. 2015. Influence of cholesterol on liposome stability and on in vitro drug release. Drug Deliv Transl Res. 5:231–242.
   PubMed Web of Science ®Google Scholar
• Cohen-Sela E, Teitlboim S, Chorny M, Koroukhov N, Danenberg HD, Gao J, Golomb G. 2009. Single and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: formulations of mithramycin and bioactivity. J Pharm Sci. 98:1452–1462.
   PubMed Web of Science ®Google Scholar
• Cosco D, Paolino D, Cilurzo F, Casale F, Fresta M. 2012. Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases. Int J Pharm. 422:229–237.
   PubMed Web of Science ®Google Scholar
• Derakhshandeh K, Fathi S. 2012. Role of chitosan nanoparticles in the oral absorption of gemcitabine. Int J Pharm. 437:172–177.
   PubMed Web of Science ®Google Scholar
• El-Nesr OH, Yahiya SA, El-Gazayerly ON. 2010. Effect of formulation design and freeze-drying on properties of fluconazole multilamellar liposomes. Saudi Pharm J. 18:217–224.
   PubMedGoogle Scholar
• Eloy JO, Claro de Souza M, Petrilli R, Barcellos JP, Lee RJ, Marchetti JM. 2014. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. Colloids Surf B Biointerfaces. 123:345–363.
   PubMed Web of Science ®Google Scholar
• Gandhi M, Pandya T, Gandhi R, Patel S, Mashru R, Misra A, Tandel H. 2015. Inhalable liposomal dry powder of gemcitabine-HCl: formulation, in vitro characterization and in vivo studies. Int J Pharm. 496:886–895.
   PubMed Web of Science ®Google Scholar
• Harris JM, Chess RB. 2004. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2:214–221.
   Web of Science ®Google Scholar
• Hinrichs WL, Manceñido FA, Sanders NN, Braeckmans K, De Smedt SC, Demeester J, Frijlink HW. 2006. The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying. Int J Pharm. 311:237–244.
   PubMed Web of Science ®Google Scholar
• Holgado MA, Arias JL, Cózar MJ, Alvarez-Fuentes J, Gañán-Calvo AM, Fernández-Arévalo M. 2008. Synthesis of lidocaine-loaded PLGA microparticles by flow focusing. Effects on Drug Loading and Release Properties. Int J Pharm. 358:27–35.
   PubMed Web of Science ®Google Scholar
• Hosta-Rigau L, Schattling P, Teo BM, Lynge ME, Stadler B. 2014. Recent progress of liposomes in nanomedicine. J Mater Chem B. 2:6686–6691.
   Web of Science ®Google Scholar
• Hou Y, Yao C, Ling L, Du Y, He R, Ismail M, Zhang Y, Fu Z, Li X. 2017. Novel dual VES phospholipid self-assembled liposomes with an extremely high drug loading efficiency. Colloids Surf B Biointerfaces. 156:29–37.
   PubMed Web of Science ®Google Scholar
• Immordino ML, Dosio F, Cattel L. 2006. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine. 1:297–315.
   PubMed Web of Science ®Google Scholar
• Jain RA. 2000. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials. 21:2475–2490.
   PubMed Web of Science ®Google Scholar
• Kadari A, Gudem S, Kulhari H, Bhandi MM, Borkar RM, Kolapalli VR, Sistla R. 2017. Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles. Drug Deliv. 24:224–232.
   PubMed Web of Science ®Google Scholar
• Li Y, Pei Y, Zhang X, Gu Z, Zhou Z, Yuan W, Zhou J, Zhu J, Gao X. 2001. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release. 71:203–211.
   PubMed Web of Science ®Google Scholar
• Liu J, Qiu Z, Wang S, Zhou L, Zhang S. 2010. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity. Biomed Mater. 5:1–10.
   Web of Science ®Google Scholar
• Liu N, Park HJ. 2009. Chitosan-coated nanoliposome as vitamin E carrier. J Microencapsul. 26:235–242.
   PubMed Web of Science ®Google Scholar
• Maherani B, Arab-tehrany E, Kheirolomoom A, Reshetov V, Stebe MJ, Linder M. 2012. Optimization and characterization of liposome formulation by mixture design. Analyst. 137:773–786.
   PubMed Web of Science ®Google Scholar
• Maitani Y, Nakamura A, Tanaka T, Aso Y. 2012. Hydration of surfactant-modified and PEGylated cationic cholesterol based liposomes and corresponding lipoplexes by monitoring a fluorescent probe and the dielectric relaxation time. Int J Pharm. 427:372–378.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 3:1377–1397.
   PubMed Web of Science ®Google Scholar
• Martín-Banderas L, Sáez-Fernández E, Holgado MÁ, Durán-Lobato MM, Prados JC, Melguizo C, Arias JL. 2013. Biocompatible gemcitabine-based nanomedicine engineered by flow focusing for efficient antitumor activity. Int J Pharm. 443:103–109.
   PubMed Web of Science ®Google Scholar
• Mehrabi M, Esmaeilpour P, Akbarzadeh A, Saffari Z, Farahnak M, Farhangi A, Chiani M. 2016. Efficacy of pegylated liposomal etoposide nanoparticles on breast cancer cell lines. Turk J Med Sci. 46:567–571.
   PubMed Web of Science ®Google Scholar
• Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN. 2007. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release. 119:77–85.
   PubMed Web of Science ®Google Scholar
• Mondalek FG, Lawrence BJ, Kropp BP, Grady BP, Fung KM, Madihally SV, Lin HK. 2008. The incorporation of poly(lactic-co-glycolic) acid nanoparticles into porcine small intestinal submucosa biomaterials. The incorporation of poly(lactic-co-glycolic) acid nanoparticles into porcine small intestinal submucosa biomaterials. Biomaterials. 29:1159–1166.
   PubMed Web of Science ®Google Scholar
• Paolino D, Cosco D, Racanicchi L, Trapasso E, Celia C, Iannone M, Puxeddu E, Costante G, Filetti S, Russo D, et al. 2010. Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. J Control Release. 144:144–150.
   PubMed Web of Science ®Google Scholar
• Seju U, Kumar A, Sawant KK. 2011. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater. 7:4169–4176.
   PubMed Web of Science ®Google Scholar
• Shi L, Wang X, Zhao F, Luan H, Tu Q, Huang Z, Wang H, Wang H. 2013. In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles. Int J Nanomedicine. 8:2669–2676.
   PubMed Web of Science ®Google Scholar
• Stevanovic M, Uskokovic D. 2009. Poly (lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins. Curr Nanosci. 5:1–14.
   Web of Science ®Google Scholar
• Tabandeh H, Mortazavi SA. 2013. An investigation into some effective factors on encapsulation efficiency of alpha-tocopherol in MLVs and the release profile from the corresponding liposomal gel. Iranian J Pharm Res. 12:21–30.
   PubMed Web of Science ®Google Scholar
• Tewes F, Munnier E, Antoon B, Ngaboni Okassa L, Cohen-Jonathan S, Marchais H, Douziech-Eyrolles L, Soucé M, Dubois P, Chourpa I. 2007. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm. 66:488–492.
   PubMed Web of Science ®Google Scholar
• Trickler WJ, Khurana J, Nagvekar AA, Dash AK. 2010. Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment. AAPS PharmSciTech. 11:392–401.
   PubMed Web of Science ®Google Scholar
• Tsotas VA, Mourtas S, Antimisiaris SG. 2007. Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability. Drug Deliv. 14:441–445.
   PubMed Web of Science ®Google Scholar
• Vali AM, Toliyat T, Shafaghi B, Dadashzadeh S. 2008. Preparation, optimization, and characterization of topotecan loaded PEGylated liposomes using factorial design. Drug Dev Ind Pharm. 34:10–23.
   PubMed Web of Science ®Google Scholar
• Vandana M, Sahoo SK. 2010. Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer. Biomaterials. 31:9340–9356.
   PubMed Web of Science ®Google Scholar
• Vaze OS. 2016. Pharmaceutical nanocarriers (liposomes and micelles) in cancer therapy. J Nanomed Nanotechnol. 7:1–2.
   Google Scholar
• Vijayakumar MR, Kosuru R, Vuddanda PR, Singh SK, Singh S. 2016. Trans resveratrol loaded DSPE PEG 2000 coated liposomes: an evidence for prolonged systemic circulation and passive brain targeting. J Drug Deliv Sci Technol. 33:125–135.
   Web of Science ®Google Scholar
• Vrignaud S, Benoit JP, Saulnier P. 2011. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials. 32:8593–8604.
   PubMed Web of Science ®Google Scholar
• Wolfram J, Suri K, Yang Y, Shen J, Celia C, Fresta M, Zhao Y, Shen H, Ferrari M. 2014. Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids Surf B Biointerfaces. 114:294–300.
   PubMed Web of Science ®Google Scholar
• Xu X, Khan MA, Burgess DJ. 2012. Predicting hydrophilic drug encapsulation inside unilamellar liposomes. Int J Pharm. 423:410–418.
   PubMed Web of Science ®Google Scholar
• Yerlikaya F, Ozgen A, Vural I, Guven O, Karaagaoglu E, Khan MA, Capan Y. 2013. Development and evaluation of paclitaxel nanoparticles using a quality-by-design approach. J Pharm Sci. 102:3748–3761.
   PubMed Web of Science ®Google Scholar